We have located links that may give you full text access.
Single-centre study reports a 84% five-year overall survival rate for paediatric solid tumours.
Acta Paediatrica 2016 August
AIM: We investigated the characteristics and outcome of paediatric patients with solid tumours diagnosed and treated at the Tampere University Hospital, one of the five tertiary referral centres in Finland, for children and adolescents with malignancies.
METHODS: This retrospective cohort study collected data from hospital medical records on survival, diagnosis, age, sex, tumour size and stage at diagnosis. We also observed the disease recurrence and use of autologous haematopoietic stem cell transplantation. Data analyses were carried out with the Kaplan-Meier method, various nonparametric and parametric tests, and Cox regression modelling.
RESULTS: Between 1987 and May 2015, 424 children (59% boys), with a median age of 6.4 (IQR 2.5-11.8) years at diagnosis, were diagnosed and followed up for a median of 7.5 (range 0-27.9) years. Central nervous system (CNS) tumours were the most common (38%), followed by lymphomas (19%), soft tissue sarcomas (10%), renal tumours (9%) and neuroblastomas (9%). The five-year overall survival rate of all solid tumour patients was 84% (95% CI, 81-88%), 82% (95% CI, 76-89%) for CNS and 85% (95% CI, 80-90%) for non-CNS tumours. Advanced tumour stage at diagnosis predicted a poor prognosis.
CONCLUSION: The treatment results in our study are comparable with those previously published. A comprehensive local database allows for a timely follow-up of the characteristics and quality of treatment of childhood malignancies.
METHODS: This retrospective cohort study collected data from hospital medical records on survival, diagnosis, age, sex, tumour size and stage at diagnosis. We also observed the disease recurrence and use of autologous haematopoietic stem cell transplantation. Data analyses were carried out with the Kaplan-Meier method, various nonparametric and parametric tests, and Cox regression modelling.
RESULTS: Between 1987 and May 2015, 424 children (59% boys), with a median age of 6.4 (IQR 2.5-11.8) years at diagnosis, were diagnosed and followed up for a median of 7.5 (range 0-27.9) years. Central nervous system (CNS) tumours were the most common (38%), followed by lymphomas (19%), soft tissue sarcomas (10%), renal tumours (9%) and neuroblastomas (9%). The five-year overall survival rate of all solid tumour patients was 84% (95% CI, 81-88%), 82% (95% CI, 76-89%) for CNS and 85% (95% CI, 80-90%) for non-CNS tumours. Advanced tumour stage at diagnosis predicted a poor prognosis.
CONCLUSION: The treatment results in our study are comparable with those previously published. A comprehensive local database allows for a timely follow-up of the characteristics and quality of treatment of childhood malignancies.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app